Inventor

JUNG SUNG YOUB

KR66 patents

⚠️ This page may combine multiple inventors who share the name “JUNG SUNG YOUB”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JUNG SUNG YOUB

HANMI PHARM IND CO LTD

Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier

Triple glucagon/GLP-1/GIP receptor agonist

Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein

Long-acting insulin or insulin analogue conjugate

Conjugate of therapeutic enzymes

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

Composition for treating hyperlipidemia comprising oxyntomodulin derivative

Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same

Glucagon derivative and a composition comprising a long acting conjugate of the same

Triple glucagon/GLP-1/GIP receptor agonist

Glucagon derivative and a composition comprising a long acting conjugate of the same

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

Glucagon derivative and a composition comprising a long acting conjugate of the same

Preparation method for high-yield production of physiologically active polypeptide conjugate

Composition for treating diabetes or diabesity comprising oxyntomodulin analog

Composition for treating hyperlipidemia comprising oxyntomodulin derivative

Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the same

Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease

Long-acting insulin and use thereof

Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate

Site-specific insulin conjugate

Insulinotropic peptide derivative with modified N-terminal charge

Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment

Modified human granulocyte-colony stimulating factor and process for producing same

Long-acting conjugates of GLP-2 derivatives

Glucagon derivatives

IgG4 Fc fragment comprising modified hinge region

Glucagon derivative, conjugate thereof, composition comprising same, and therapeutic use thereof

Glucagon derivatives with improved stability

HANMI SCIENCE CO LTD

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

IgG Fc fragment for a drug carrier and method for the preparation thereof

Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof

Blood coagulation factor VII and VIIa derivatives, conjugates and complexes comprising the same, and use thereof

Site-specific GLP-2 conjugate using an immunoglobulin fragment

Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof

IgG Fc fragment for a drug carrier and method for the preparation thereof

JUNG SUNG YOUB

Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof

N-terminal modified exendin-4

IgG Fc fragment for a drug carrier and method for the preparation thereof

Method for treating cancer using an interferon alpha conjugate

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

HANMI HOLDINGS CO LTD

Method for the mass production of immunoglobulin constant region

Method for the mass production of immunoglobulin Fc region deleted initial methionine residues

SONG DAE HAE

Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate

Insulinotropic complex using an immunoglobulin fragment

KIM YOUNG MIN

Pharmaceutical composition comprising an immunoglobulin FC region as a carrier

KIM DAE JIN

Long-acting interferon beta formulation comprising an immunoglobulin fragment

WOO YOUNG EUN

Long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity

HANMI PHARMACEUTICAL CO LTD

Glucagon derivatives